PAST WAP DISTINGUISHED LECTURES
| (D): | Distinguished Lectures (1966-74) sponsored by Hyland Laboratories
| (K):
| Kroc Foundation (1975 - 2002)
| (KFF):
| Kaiser Family Foundation (1981-1989) | (WAP):
| WAP Lectureship (1990 - current) |
1966 In Pursuit of the Purple (D) Cecil Watson, Minneapolis, MN Presidential Address: A Reaction to the Antileadership Vaccine (D) Halsted Holman, Palo Alto, CA (JW Gardner Science, 1966)
1967 The Danger of Adaptation (D) Rene Dubos, New York City, NY Brian McCarthy
1968 Immunohemolytic Anemias (D) James H. Jandl, Boston MA 1969 A Progress Report to Metchnikoff (D) W. Barry Wood, Jr, Baltimore, MD
1970 Travail and Trivia: Trials of Medical Publication (D) Franz J. Ingelfinger, Boston MA
1971 Progressive Pernicious Anemia: From Fatality to Felicity (D) William B. Castle, W Roxbury, MA
1972 RNA Tumor Viruses and Human Cancer (D) Sol Spiegelman, New York, NY
1973 Ion Exchange and Contractility in the Myocardium (D) Glenn Langer, Los Angeles, CA
1974 Cellular and Macromodecular Engineering - Realities and Potentialities (D) Robert A. Good, New York, NY Kroc Foundation (1975 - 2002)
1975 The Metabolic Code(K)Gordon M. Tomkins, UCSF 1976 The Hormonal Control of Growth (K) William Daughaday,Washington University, St. Louis
1977 Recent Studies with Peptides of the Hypothalamus (K) Roger Guillemin, Salk Institute
1978 Transport in Tight and Leaky Epithelia (K) Jared Diamond, UCLA. Special Lecture on Epithelia (K) Rosalyn Yalow
1979 Familial Hypercholesterolemia: Insights into the Pahtogenesis of Atherosclerosis (K) Joseph Goldstein, U. of Texas
1980 Immunoregulatory Mechanisms: Insight Derived from Patients with Primary Immunodeficiency Disease or with Leukemia (K) Thomas A. Waldmann, National Cancer Institute
1981 Prostaglandins: Discoveries and Potential for Therapeutics Philip Needleman,Washington University, St. Louis, MO Medical Technology: The Challenge of the 1980's (KFF) Philip R. Lee, UCSF
1982 Studies of the Pathogenesis of Systemic Lupus Erythematosus (K) Robert Schwartz,Tufts University SOM, Boston, MA Cancelled due to illness of lecturer (KFF) Baruj Bonacerref
1983 (KFF) James B. Wyngaarden, Director, NIH
1984 Antibodies: The Proteins and their Genes (K) Leroy E. Hood, Pasadena, CA A Randomized Controlled Trial: Does Free Care Improve the Health of Adults?(KFF) Robert H. Brook, Los Angeles, CA
1985 Oncogenes and Retroviruses in Human Cancer (K) Stuart Aaronson, National Cancer Institute.The Computer as a Tool for Clinical Decision Making: Artificial Intelligence in Medicine (KFF) Edward Shortliffe, Stanford, CA
1986 The Acquired Immune Deficiency Syndrome (AIDS) An Update Anthony S. Fauci, NIH, Bethesda, MDBack to the Future: Are New Standards Needed in Medical Care? (KFF) John A. Benson, Portland, OR
1987 Mapping Approaches to Gene Identification in Humans (K) Raymond White, Salt Lake City, UT. Some Thoughts on Medical Center Governance (KFF) Robert Petersdorf, President, AAMC
1988 Cancer Genes: From Bench to Bedside(K) J. Michael Bishop, UCSF Science and Health Care Policy: Who Decides?(KFF) Samuel O. Their, National Academy of Science, Washington, D.C.
1989 Advances in Neurosciences: Implications for Medicine (K) Floyd E. Bloom, Scripps Clinic, La Jolla, CA.The Canadian Healthcare System in Relation to Current Problems in the United States (KFF) Gerard N. Burrow, UCSD
1990 Brain Mechanisms of Sound Localization (K) Masakazu Konishi, Calif. Institute of Technology, Pasadena, CA Peer Review in Scientific Journals: What Good Is It?(WAP) Arnold S. Relman, Editor-in-Chief, NEJM
1991 The AIDS Virus: What We Know and What We Can Do About It? (K) Flossie Wong-Stall, UCSD Irresistible Medical Technonolgy: Cost, Quality and Equity in Health Care (WAP) Harvey V. Fineberg,Harvard School of Public Health, Boston, MA
1992 Present Understanding of Blood Coagulation and It’s Alterations in Hemorrhage and Thromotic Disorder Samuel I. Rapaport, San Diego, CA Oncogenes and Antioncogenes. The Legacies of Peyton Rous and Theodor Peter Vogt, Los Angeles, CA
1993 Paradoxical Dilemmas in Body Fluid Volume Regulation in Health and Disease - A Unifying Hypothesis Robert W. Schrier, Denver, CO Academe and Government: Firm Link or Broken Reed Robert Petersdorf, Washington, D.C.
1994 Emergence of a New Hantavirus Disease in the Four Corners Region of the United States Brian Lief Hjelle, Albuquerque, NM. The Future of Health Policy Victor R. Fuchs, Stanford, CA
1995 Carbohydrates as Recognition Molecules: Role inHuman Biology and Diseases Stuart Kornfield, St Luis, MO. Two Revolutions: Copernicus and Darwin Francisco J. Ayala, Irvine CA
1996 The Future of Academic Health Centers Samuel O. Their, Boston, MA. Renal Epithelial Cell Function and Organization in Normal and Disease States W. James Nelson, Stanford, CA
1997 Current and Future NIH Support of Biomedical Research Claude Lenfant, NIH. AIDS Merle Sande, University of Utah
1998 Evolving Nature of Pharmaceutical Industry Research:Leon Rosenberg, MD, Implications for Collaboration with Academia (K) Bristol-Meyers Squibb, Princeton, NJ. STD's: Progress and Problems for the year 2000 (WAP) King K Holmes, MD, PhD, U of WA
1999 Neuroendocrinology of Inflammation and Innate Immunity (WAP/KROC) Seymour Reichlin, University of Arizona
2000 Nitric Oxide in Innate Resistance and Immunity (K) John Hibbs, University of Utah
2001 Beyond the Human Genome Project: What Comes Next? (K) Maynard Olson, Seattle, WA
2002 Clinical Research in the 21st Century - Linking Discovery to Healing (K) Philip Eaton, University of New Mexico
2003 The IKK Complex: A Central Regulator of Inflammatory and Immune Responses Michael Karin, UC, San Diego
2004 Living Off the Fat of the Land - An Intersection of the Pharmaceutical Regulatory and Health Care Establishments (K) Michael Friedman, City of Hope Hospital
WAP Symposium: INDUSTRY, ACADEMICS, AND THE HEALTH OF PATIENTS AND THE PUBLIC
The Good News: Orphan Drug Development – Treatment Of Lysosomal Storage Disease.
Gregory Grabowski, University of Cincinnati
The Bad News: The Withdrawal Of The Pharmaceutical Industry From Anti-Infective Research And Development.
Steve Projan, Wyeth-Ayerst
What May Be Done: How We Can Seize Opportunities And Resolve Conflicts Between The Academy And Pharmaceutical Interests.
Michael Friedman, City of Hope National Medical Center
2005 Nitric Oxide and Cyclic GMP in Cell Signaling and Drug Development. Ferid Murad, University of Texas Health Sciences Center
WAP Symposium: THE IMPACT OF "OMICS" ON MODERN MEDICINE
Genomics: Human Genetic Variation And Complex Human Traits.
David R. Cox, Perlegen Sciences, Inc.
Glycomics: Life Sugar-Coded.
James Paulson, The Scripps Research Institute
Proteomics: Comparative Proteomics – Diagnostics And Prognostics For The 21st Century.
Harvey Joel Cohen, Lucille Packard Children's Hospital
2006 Genetic Analysis of Human Embryonic Stem Cell-Derived Germ Cells. Renee Reijo Pera, University of California, San Francisco
WAP Symposium:
PATHOPHYSIOLOGY OF SEPTIC SHOCK: NEW KNOWLEDGE AND NEW TREATMENT OPPORTUNITIES
For Whom The Bell Tolls: Advances In The Innate Immune Response To Sepsis.
David Gilbert, Oregon Health & Science University
Coagulopathy In Sepsis.
Tom DeLoughery, Oregon Health & Science University
Glucocorticoids And Septic Shock.
Brent Wisse, University of Washington
2007 Perspectives and Progress on Developing a Useful HIV Vaccine Lawrence Corey, University of Washignton
WAP Symposium: INTERPLAY OF OXIDATIVE STRESS, INFLAMMATION, DYSLIPIDEMIA AND HYPERTENSION IN THE PATHOGENESIS OF CARDIOVASCULAR DISEASE
Convergence Of Lipid And Oxidation Hypotheses Of Atherosclerosis.
Mohammad Navab, David Geffen School of Medicine at UCLA
The Vicious Cycle Of Hypertension, Oxidative Stress, And Inflammation.
Nick D. Vaziri, University of California, Irvine
Homocysteine, B Vitamins And Cardiovascular Disease.
Ralph Green, University of California, Davis
2008 Mitochondrial DNA, Oxidative Stress And Aging. Douglas C. Wallace, University Of California, Irvine
WAP Symposium: INTERPLAY OF OXIDATIVE STRESS, INFLAMMATION, DYSLIPIDEMIA AND HYPERTENSION IN THE PATHOGENESIS OF CARDIOVASCULAR DISEASE
Genetics Of Obesity.
Christian Vaisse, University of California, San Francisco
Inflammation And Insulin Resistance/Diabetes.
Jerrold Olefsky, University of California, San Diego
Novel Approaches To Treatment.
Jonathan Purnell, Oregon Health & Science University
Metabolic Underpinnings Of Bariatric Surgery.
David Cummings, University Washington
2009 WAP Distinguished Lectureship:
EXERCISE, MITOCHONDRIA AND METABOLIC PHENOTYPE. David E. Kelley, Merck and Company
WAP Symposium: EVOLUTIONARY PATHOBIOLOGY OF ATHEROSCLEROSIS (THROMBOSIS, INFLAMMATION AND LIPIDS)
Thrombosis.
Ethan Weiss, University of California, San Francisco
Inflammation.
Christopher Glass, University of California, San Diego
Lipids.
Alan Chait, University of Washington
2010 WAP Distinguished Lectureship:
HOW BACTERIA LOOK AT THE WORLD.
Stanley Falkow, Stanford University School of Medicine
WAP Symposium: BAD BUGS; NO DRUGS
Bad Bugs; No Drugs – Where Have We Been, Where Are We Now, And Where Are We Going? Brad Spellberg, David Geffen School of Medicine at UCLA and Harbor-UCLA Medical Center
Mrsa Virulence Factors And New Targets For Treatment.
Henry (Chip) F. Chambers, San Francisco General Hospital and University of California, San Francisco
Fungal Infections – Not All Bad Bugs Are Bacteria.
John E. Edwards, Jr., Harbor-UCLA Medical Center and David Geffen School of Medicine at UCLA
2011 WAP Distinguished Lectureship:
CURRENT CHALLENGES AND OPPORTUNITIES IN GLOBAL HEALTH.
King Holmes, University of Washington
WAP Symposium: GLOBAL HEALTH: THE SPECTER OF CANCER, MALNUTRITION, AND INFECTION
Innovation To Impact: Cervical Cancer Prevention.
Jacqueline Sherris, Program for Appropriate Technology in Health (PATH)
Vitamin D Insufficiency And Innate Immunodysfunction.
John S. Adams, David Geffen School of Medicine at UCLA
Drug Development For Neglected Infectious Diseases: New Hope For Old Scourges.
Wesley Van Voorhis, University of Washington
2012 WAP Distinguished Lectureship:
HEART BREAKING AND HEART MAKING: NEW STRATEGIES FOR CARDIAC
REGENERATION.
Eric Olson, University of Texas Southwestern
WAP Symposium: STEM CELL THERAPEUTICS FOR THE CARDIOVASCULAR SYSTEM:
HOPE OR HYPE
Pluripotent Stem Cells For Cardiac Repair.
Michael Laflamme, University of Washington
Steps Toward Bioartificial Organs For Transplantation.
Doris Taylor, University of Minnesota
The Holy Grail Of Cell Therapy: Can We Achieve Genuine
Regeneration?
Eduardo Marban, Cedars Sinai Medical Center
2013 WAP Distinguished Lectureship: WHO ARE WE? THE HUMAN MICROBIOME IN HEALTH AND DISEASE.
David Relman, Stanford University. WAP Symposium: THE MICROBIOME AND ITS CONTRIBUTIONS TO HEALTH AND DISEASE
The role of innate immune response genes in
maintaining the gut microbiome and protection from inflammatory bowel disease. R. William De Paolo, University of Southern California
Vaginal ecology in health and disease: the role of the vaginal microbiome. Jeannie Marrazzo, University of Washington
Small molecules from the human microbiota. Michael Fischbach, University of California,
San Francisco.
Western Association of Physicians
|
